Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 6543.00 | 6344.00 | 1.0314 | 1.0759 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 3570.27 | 6357.00 | 6344.00 | 1.0020 | 1.0049 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5714.00 | 6344.00 | 0.9007 | 0.7630 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 4407.00 | 6344.00 | 0.6947 | 0.2890 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6140.00 | 6344.00 | 0.9678 | 0.9227 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3173.00 | 6344.00 | 0.5002 | -0.1326 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6469.00 | 6344.00 | 1.0197 | 1.0476 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5641.00 | 6344.00 | 0.8892 | 0.7359 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 6383.00 | 6344.00 | 1.0061 | 1.0148 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 5000.00 | 3570.27 | 2462.00 | 6344.00 | 0.3881 | -0.3612 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 6254.00 | 6344.00 | 0.9858 | 0.9658 | |
| SK-BR-3 | 0 | uM | 9 | 156.25 | 92.36 | 145.00 | 144.75 | 1.0017 | 1.0053 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 156.25 | 92.36 | 125.00 | 144.75 | 0.8636 | 0.5949 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 156.25 | 92.36 | 130.00 | 144.75 | 0.8981 | 0.6944 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 192.00 | 144.75 | 1.3264 | 2.0925 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 156.25 | 92.36 | 114.00 | 144.75 | 0.7876 | 0.3836 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 156.25 | 92.36 | 34.00 | 144.75 | 0.2349 | -0.7860 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 217.00 | 144.75 | 1.4991 | 2.7353 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 156.25 | 92.36 | 184.00 | 144.75 | 1.2712 | 1.8959 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 156.25 | 92.36 | 212.00 | 144.75 | 1.4646 | 2.6033 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 156.25 | 92.36 | 79.00 | 144.75 | 0.5458 | -0.2143 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 156.25 | 92.36 | 144.00 | 144.75 | 0.9948 | 0.9840 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 156.25 | 92.36 | 143.00 | 144.75 | 0.9879 | 0.9628 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 156.25 | 92.36 | 51.00 | 144.75 | 0.3523 | -0.6000 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 156.25 | 92.36 | 205.00 | 144.75 | 1.4162 | 2.4214 |